Enforcement record
先駆け審査指定制度対象品目の募集 disclosure naming 大日本住友製薬 株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
先駆け審査指定制度対象品目の募集
Law
Pharmaceutical Affairs Act
Authority
Ministry of Health, Labour and Welfare
Action date
5 October 2017
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Completed archive verified
- Captured: Jul 12, 2026, 03:35 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Open the official source links in the section below to review the original disclosure.
Action summary
- Company
- 大日本住友製薬 株式会社Japanese onlyOriginal: 大日本住友製薬 株式会社
- Governing law
- Pharmaceutical Affairs Act薬事法
- Action type
- 先駆け審査指定制度対象品目の募集先駆け審査指定制度対象品目の募集
- Action date
- 5 October 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Unapproved Parkinson's disease treatment using non-self iPS cell-derived dopamine neural precursor cells
Show original Japanese text
非自己iPS細胞由来ドパミン神経前駆細胞 パーキンソン病
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under Pharmaceutical Affairs Act.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive
- Extracted at
- 2026-04-24T23:38:31.066+00:00
- Evidence checked
- 2026-04-24T23:38:31.066+00:00
- Archive captured
- 2026-07-12T06:35:06.810541+00:00
Show audit JSON
{
"record": {
"id": "0ad675eb-1ab8-4608-821c-ec979b190fa8",
"url": "https://regbase.jp/en/enforcement/other-da-ri-ben-zhu-you-zhi-yao-20171005",
"company_name_original": "大日本住友製薬 株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "薬事法",
"en": "Pharmaceutical Affairs Act"
},
"action_type": {
"ja": "先駆け審査指定制度対象品目の募集",
"en": "先駆け審査指定制度対象品目の募集"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": "The linked company profile has not been verified under the current identity policy."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under Pharmaceutical Affairs Act."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-da-ri-ben-zhu-you-zhi-yao-20171005",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000179802.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/ceb343f564hf0jc8",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000179802.html",
"archiveCapturedAt": "2026-07-12T06:35:06.810541+00:00",
"extractedAt": "2026-04-24T23:38:31.066+00:00",
"translatedAt": "2026-05-01T06:52:29.101+00:00",
"evidenceCheckedAt": "2026-04-24T23:38:31.066+00:00",
"generatedAt": "2026-09-18T21:00:36.700Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.